# Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)

> **NCT00794599** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 118 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Desloratadine 5 mg (Clarinex)
- **DRUG:** Cetirizine (Zyrtec)

## Key facts

- **NCT ID:** NCT00794599
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794599, "Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00794599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*